Sepsis in old age: Review of human and animal studies

Aging and Disease

Volumn 5, Issue 2, 2014, Pages 126-136

  Starr, Marlene E ^a,b   Saito, Hiroshi ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Animal models; Coagulation; Elderly; Inflammation; Sepsis

Indexed keywords

ANIMALIA;

EID: 84910682303     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500126     Document Type: Review

References (113)

1. Podnos YD, Jimenez JC, Wilson SE (2002). Intra-abdominal Sepsis in Elderly Persons. Clin Infect Dis, 35: 62-68
2. Kale SS, Yende S (2011). Effects of Aging on Inflammation and Hemostasis through the Continuum of Critical Illness. Aging Dis, 2: 501-511
3. Opal SM, Girard TD, Ely EW (2005). The immunopathogenesis of sepsis in elderly patients. Clin Infect Dis, 41 Suppl 7: S504-512
4. Pisani MA (2009). Considerations in caring for the critically ill older patient. J Intensive Care Med, 24: 83-95
5. Wier M, RMAndrews (2011) The National Hospital Bill: The Most Expensive Conditions by Payer, 2008 (HCUP, ed) Vol. Statistical Brief #107
6. Andrews R, Elixhauser A (2007) The National Hospital Bill: Growth Trends and 2005 Update on the Most Expensive Conditions by Payer. In Healthcare Costs and Utilization Project Vol. Statistical Brief #42
7. Angus DC, van der Poll T (2013). Severe sepsis and septic shock. N Engl J Med, 369: 2063
8. Torpy JM, Lynm C, Glass RM (2009). JAMA patient page. Intensive care units. JAMA, 301: 1304
9. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001). Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med, 29: 1303-1310
10. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. (2006). Sepsis in European intensive care units: results of the SOAP study. Crit Care Med, 34: 344-353
11. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS (2006). The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med, 34: 2576-2582
12. Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, et al. (2002). Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med, 28: 108-121
13. Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D (2003). Cytokine cascade in sepsis. Scand J Infect Dis, 35: 535-544
14. Philippart F, Cavaillon J, Dinarello C (2009) Inflammatory Mediators. In Sepsis and Non-infectious Systemic Inflammation (Cavaillon, J., Adrie, C., eds) pp. 177-204, Wiley-VCH, Weinheim
15. Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, et al. (2013). Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiol Rev, 93: 1247-1288
16. Esmon CT, Fukudome K, Mather T, Bode W, Regan LM, Stearns-Kurosawa DJ, et al. (1999). Inflammation, sepsis, and coagulation. Haematologica, 84: 254-259
17. Opal SM, Esmon CT (2003). Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care, 7: 23-38
18. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. (2013). Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med, 41: 580-637
19. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK (2012). Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med, 40: 754-761
20. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2007). Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med, 35: 1244-1250
21. Wester AL, Dunlop O, Melby KK, Dahle UR, Wyller TB (2013). Age-related differences in symptoms, diagnosis and prognosis of bacteremia. BMC Infect Dis, 13: 346
22. Girard TD, Opal SM, Ely EW (2005). Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clin Infect Dis, 40: 719-727
23. Girard TD, Ely EW (2007). Bacteremia and sepsis in older adults. Clin Geriatr Med, 23: 633-647, viii
24. Martin GS, Mannino DM, Eaton S, Moss M (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med, 348: 1546-1554
25. Gaieski DF, Edwards JM, Kallan MJ, Carr BG (2013). Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med, 41: 1167-1174
26. Heron M (2012) Deaths: Leading causes for 2009. (Statistics, N. C. f. H., ed) Vol. 61, Hyattsville, MD
27. Martin GS, Mannino DM, Moss M (2006). The effect of age on the development and outcome of adult sepsis. Crit Care Med, 34: 15-21
28. Reade M, Angus D (2009) Epidemiology of Sepsis and Non-infectious SIRS. In Sepsis and Non-infectious Systemic Inflammation (Cavaillon, J., Adrie, C., eds) pp. 13-39, Wiley-VCH, Weinheim
29. Ely EW, Angus DC, Williams MD, Bates B, Qualy R, Bernard GR (2003). Drotrecogin alfa (activated) treatment of older patients with severe sepsis. Clin Infect Dis, 37: 187-195
30. Carbajal-Guerrero J, Cayuela-Dominguez A, Fernandez-Garcia E, Aldabo-Pallas T, Marquez-Vacaro JA, Ortiz-Leyba C, et al. (2013). Epidemiology and long-term outcome of sepsis in elderly patients [published online ahead of print Feb 22, 2013]. Med Intensiva, doi 10.1016/j.medin.2012.12.006
31. Lemay AC, Anzueto A, Restrepo MI, Mortensen EM (2013). Predictors of Long-term Mortality After Severe Sepsis in the Elderly [published online ahead of print May 17, 2013]. Am J Med Sci, doi 10.1097/MAJ.0b013e318295a147
32. De Gaudio AR, Rinaldi S, Chelazzi C, Borracci T (2009). Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr Drug Targets, 10: 60-70
33. Miller RA (1996). The aging immune system: primer and prospectus. Science, 273: 70-74
34. Grubeck-Loebenstein B, Berger P, Saurwein-Teissl M, Zisterer K, Wick G (1998). No immunity for the elderly. Nat Med, 4: 870
35. Chou JP, Effros RB (2013). T cell replicative senescence in human aging. Curr Pharm Des, 19: 1680-1698
36. McElhaney JE, Effros RB (2009). Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol, 21: 418-424
37. Dewan SK, Zheng SB, Xia SJ, Bill K (2012). Senescent remodeling of the immune system and its contribution to the predisposition of the elderly to infections. Chin Med J (Engl), 125: 3325-3331
38. Weksler ME, Goodhardt M, Szabo P (2002). The effect of age on B cell development and humoral immunity. Springer Semin Immunopathol, 24: 35-52
39. Gomez CR, Nomellini V, Faunce DE, Kovacs EJ (2008). Innate immunity and aging. Exp Gerontol, 43: 718-728
40. Cohen HJ, Harris T, Pieper CF (2003). Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med, 114: 180-187
41. Krabbe KS, Pedersen M, Bruunsgaard H (2004). Inflammatory mediators in the elderly. Exp Gerontol, 39: 687-699
42. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, et al. (2002). Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med, 162: 2333-2341
43. Kale S, Yende S, Kong L, Perkins A, Kellum JA, Newman AB, et al. (2010). The effects of age on inflammatory and coagulation-fibrinolysis response in patients hospitalized for pneumonia. PLoS One, 5: e13852
44. Naffaa M, Makhoul BF, Tobia A, Kaplan M, Aronson D, Saliba W, et al. (2013). Interleukin-6 at discharge predicts all-cause mortality in patients with sepsis. Am J Emerg Med, 31: 1361-1364
45. Marik PE, Zaloga GP (2001). The effect of aging on circulating levels of proinflammatory cytokines during septic shock. Norasept II Study Investigators. J Am Geriatr Soc, 49: 5-9
46. Bruunsgaard H, Skinhoj P, Qvist J, Pedersen BK (1999). Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis, 180: 551-554
47. Boldt J, Muller M, Heesen M, Papsdorf M, Hempelmann G (1997). Does age influence circulating adhesion molecules in the critically ill? Crit Care Med, 25: 95-100
48. Levi M (2010). The coagulant response in sepsis and inflammation. Hamostaseologie, 30: 10-12, 14-16
49. Levi M, de Jonge E, van der Poll T (2003). Sepsis and disseminated intravascular coagulation. J Thromb Thrombolysis, 16: 43-47
50. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenberg RD (1995). Hypercoagulability in centenarians: the paradox of successful aging. Blood, 85: 3144-3149
51. Alexander SL, Ernst FR (2006). Use of drotrecogin alfa (activated) in older patients with severe sepsis. Pharmacotherapy, 26: 533-538
52. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. (2013). Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A, 110: 3507-3512
53. Zanotti-Cavazzoni SL, Goldfarb RD (2009). Animal models of sepsis. Crit Care Clin, 25: 703-719
54. Flurkey K, Currer J, Harrison D (2007) Mouse Models in Aging Research. In The Mouse in Biomedical Research (Fox JG, e. a., ed) pp. 637-372
55. Rittirsch D, Hoesel LM, Ward PA (2007). The disconnect between animal models of sepsis and human sepsis. J Leukoc Biol, 81: 137-143
56. Esmon CT (2004). Why do animal models (sometimes) fail to mimic human sepsis? Crit Care Med, 32: S219-222
57. Nomellini V, Gomez CR, Kovacs EJ (2008). Aging and impairment of innate immunity. Contrib Microbiol, 15: 188-205
58. Kovacs EJ, Palmer JL, Fortin CF, Fulop T, Jr., Goldstein DR, Linton PJ (2009). Aging and innate immunity in the mouse: impact of intrinsic and extrinsic factors. Trends Immunol, 30: 319-324
59. Finch C (1990) Longevity, senescence, and the genome, University of Chicago Press, Chicago
60. Okamura D, Starr ME, Lee EY, Stromberg AJ, Evers BM, Saito H (2012). Age-dependent vulnerability to experimental acute pancreatitis is associated with increased systemic inflammation and thrombosis. Aging Cell, 11: 760-769
61. Saito H, Papaconstantinou J (2001). Age-associated differences in cardiovascular inflammatory gene induction during endotoxic stress. J Biol Chem, 276: 29307-29312
62. Saito H, Sherwood ER, Varma TK, Evers BM (2003). Effects of aging on mortality, hypothermia, and cytokine induction in mice with endotoxemia or sepsis. Mech Ageing Dev, 124: 1047-1058
63. Starr ME, Evers BM, Saito H (2009). Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J Gerontol A Biol Sci Med Sci, 64: 723-730
64. Starr ME, Hu Y, Stromberg AJ, Carmical JR, Wood TG, Evers BM, et al. (2013). Gene expression profile of mouse white adipose tissue during inflammatory stress: age-dependent upregulation of major procoagulant factors. Aging Cell, 12: 194-206
65. Starr ME, Saito H (2012). Age-related increase in food spilling by laboratory mice may lead to significant overestimation of actual food consumption: implications for studies on dietary restriction, metabolism, and dose calculations. J Gerontol A Biol Sci Med Sci, 67: 1043-1048
66. Starr ME, Ueda J, Takahashi H, Weiler H, Esmon CT, Evers BM, et al. (2010). Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin. Blood, 115: 4886-4893
67. Starr ME, Ueda J, Yamamoto S, Evers BM, Saito H (2011). The effects of aging on pulmonary oxidative damage, protein nitration and extracellular superoxide dismutase down-regulation during systemic inflammation. Free Radic Biol Med, 50: 371-380
68. Hubbard WJ, Choudhry M, Schwacha MG, Kerby JD, Rue LW, 3rd, Bland KI, et al. (2005). Cecal ligation and puncture. Shock, 24 Suppl 1: 52-57
69. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA (2009). Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc, 4: 31-36
70. Ebong S, Call D, Nemzek J, Bolgos G, Newcomb D, Remick D (1999). Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun, 67: 6603-6610
71. Turnbull IR, Wlzorek JJ, Osborne D, Hotchkiss RS, Coopersmith CM, Buchman TG (2003). Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock, 19: 310-313
72. Turnbull IR, Clark AT, Stromberg PE, Dixon DJ, Woolsey CA, Davis CG, et al. (2009). Effects of aging on the immunopathologic response to sepsis. Crit Care Med, 37: 1018-1023
73. Drechsler S, Weixelbaumer K, Raeven P, Jafarmadar M, Khadem A, van Griensven M, et al. (2012). Relationship between age/gender-induced survival changes and the magnitude of inflammatory activation and organ dysfunction in post-traumatic sepsis. PLoS One, 7: e51457
74. Gomez CR, Goral J, Ramirez L, Kopf M, Kovacs EJ (2006). Aberrant acute-phase response in aged interleukin-6 knockout mice. Shock, 25: 581-585
75. Habicht GS (1981). Body temperature in normal and endotoxin-treated mice of different ages. Mech Ageing Dev, 16: 97-104
76. Chorinchath BB, Kong LY, Mao L, McCallum RE (1996). Age-associated differences in TNF-alpha and nitric oxide production in endotoxic mice. J Immunol, 156: 1525-1530
77. Tateda K, Matsumoto T, Miyazaki S, Yamaguchi K (1996). Lipopolysaccharide-induced lethality and cytokine production in aged mice. Infect Immun, 64: 769-774
78. Horan MA, Brouwer A, Barelds RJ, Wientjens R, Durham SK, Knook DL (1991). Changes in endotoxin sensitivity in ageing. Absorption, elimination and mortality. Mech Ageing Dev, 57: 145-162
79. Emmerling P, Hof H, Finger H (1979). Age-related defense against infection with intracellular pathogens. Gerontology, 25: 327-336
80. Patel PJ (1981). Aging and cellular defense mechanisms: age-related changes in resistance of mice to Listeria monocytogenes. Infect Immun, 32: 557-562
81. Tocco-Bradley R, Kluger MJ, Kauffman CA (1985). Effect of age on fever and acute-phase response of rats to endotoxin and Salmonella typhimurium. Infect Immun, 47: 106-111
82. Louria DB, Lavenhar MA, Kaminski T, Buse M, Kaplan M (1986). Staphylococcal infections in aging mice. J Gerontol, 41: 718-722
83. Orme IM (1987). Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J Immunol, 138: 4414-4418
84. Maddens B, Vandendriessche B, Demon D, Vanholder R, Chiers K, Cauwels A, et al. (2012). Severity of sepsis-induced acute kidney injury in a novel mouse model is age dependent. Crit Care Med, 40: 2638-2646
85. Antonini JM, Roberts JR, Clarke RW, Yang HM, Barger MW, Ma JY, et al. (2001). Effect of age on respiratory defense mechanisms: pulmonary bacterial clearance in Fischer 344 rats after intratracheal instillation of Listeria monocytogenes. Chest, 120: 240-249
86. Mares CA, Sharma J, Ojeda SS, Li Q, Campos JA, Morris EG, et al. (2010). Attenuated response of aged mice to respiratory Francisella novicida is characterized by reduced cell death and absence of subsequent hypercytokinemia. PLoS One, 5: e14088
87. Esposito AL, Pennington JE (1983). Effects of aging on antibacterial mechanisms in experimental pneumonia. Am Rev Respir Dis, 128: 662-667
88. Little CS, Bowe A, Lin R, Litsky J, Fogel RM, Balin BJ, et al. (2005). Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice. Infect Immun, 73: 1723-1734
89. Shivshankar P, Boyd AR, Le Saux CJ, Yeh IT, Orihuela CJ (2011). Cellular senescence increases expression of bacterial ligands in the lungs and is positively correlated with increased susceptibility to pneumococcal pneumonia. Aging Cell, 10: 798-806
90. Southam DS, Dolovich M, O'Byrne PM, Inman MD (2002). Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia. Am J Physiol Lung Cell Mol Physiol, 282: L833-839
91. Hyde SR, McCallum RE (1992). Lipopolysaccharide-tumor necrosis factor-glucocorticoid interactions during cecal ligation and puncture-induced sepsis in mature versus senescent mice. Infect Immun, 60: 976-982
92. Wu R, Zhou M, Dong W, Ji Y, Miksa M, Marini CP, et al. (2009). Ghrelin hyporesponsiveness contributes to age-related hyperinflammation in septic shock. Ann Surg, 250: 126-133
93. Akaiwa M, Yu B, Umeshita-Suyama R, Terada N, Suto H, Koga T, et al. (2001). Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine, 13: 75-84
94. Foster KD, Conn CA, Kluger MJ (1992). Fever, tumor necrosis factor, and interleukin-6 in young, mature, and aged Fischer 344 rats. Am J Physiol, 262: R211-215
95. Zhou M, Wu R, Dong W, Leong J, Wang P (2010). Accelerated apoptosis contributes to aging-related hyperinflammation in endotoxemia. Int J Mol Med, 25: 929-935
96. Remick DG, Bolgos GR, Siddiqui J, Shin J, Nemzek JA (2002). Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock, 17: 463-467
97. Remick DG, Bolgos G, Copeland S, Siddiqui J (2005). Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun, 73: 2751-2757
98. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, et al. (1998). IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest, 101: 311-320
99. Ulich TR, Guo KZ, Remick D, del Castillo J, Yin SM (1991). Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J Immunol, 146: 2316-2323
100. Saito H, Patterson C, Hu Z, Runge MS, Tipnis U, Sinha M, et al. (2000). Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia. Am J Physiol Heart Circ Physiol, 279: H2241-2248
101. Riedemann NC, Neff TA, Guo RF, Bernacki KD, Laudes IJ, Sarma JV, et al. (2003). Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol, 170: 503-507
102. Clemmer TP, Fisher CJ, Jr., Bone RC, Slotman GJ, Metz CA, Thomas FO (1992). Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med, 20: 1395-1401
103. Tiruvoipati R, Ong K, Gangopadhyay H, Arora S, Carney I, Botha J (2010). Hypothermia predicts mortality in critically ill elderly patients with sepsis. BMC Geriatr, 10: 70
104. Gomez CR, Nomellini V, Baila H, Oshima K, Kovacs EJ (2009). Comparison of the effects of aging and IL-6 on the hepatic inflammatory response in two models of systemic injury: scald injury versus i.p. LPS administration. Shock, 31: 178-184
105. Gomez CR, Hirano S, Cutro BT, Birjandi S, Baila H, Nomellini V, et al. (2007). Advanced age exacerbates the pulmonary inflammatory response after lipopolysaccharide exposure. Crit Care Med, 35: 246-251
106. Tucsek Z, Gautam T, Sonntag WE, Toth P, Saito H, Salomao R, et al. (2013). Aging exacerbates microvascular endothelial damage induced by circulating factors present in the serum of septic patients. J Gerontol A Biol Sci Med Sci, 68: 652-660
107. Turnbull IR, Buchman TG, Javadi P, Woolsey CA, Hotchkiss RS, Karl IE, et al. (2004). Age disproportionately increases sepsis-induced apoptosis in the spleen and gut epithelium. Shock, 22: 364-368
108. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, et al. (1999). Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med, 27: 1230-1251
109. Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, et al. (2002). Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock, 18: 487-494
110. Roger PM, Hyvernat H, Ticchioni M, Kumar G, Dellamonica J, Bernardin G (2012). The early phase of human sepsis is characterized by a combination of apoptosis and proliferation of T cells. J Crit Care, 27: 384-393
111. Gharacholou SM, Becker RC (2009). Hemostasis and thrombosis in older adults. J Thromb Thrombolysis, 27: 249-251
112. Wilkerson WR, Sane DC (2002). Aging and thrombosis. Semin Thromb Hemost, 28: 555-568
113. Yamamoto K, Shimokawa T, Yi H, Isobe K, Kojima T, Loskutoff DJ, et al. (2002). Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol, 161: 1805-1814